@article{39e83dbcaf2c40909bf871acfe3261aa,
title = "Prediction of medial tibiofemoral compartment joint space loss progression using volumetric cartilage measurements: Data from the FNIH OA biomarkers consortium",
abstract = "Objectives: Investigating the association between baseline cartilage volume measurements (and initial 24th month volume loss) with medial compartment Joint-Space-Loss (JSL) progression (>0.7 mm) during 24–48th months of study. Methods: Case and control cohorts (Biomarkers Consortium subset from the Osteoarthritis Initiative (OAI)) were defined as participants with (n=297) and without (n=303) medial JSL progression (during 24–48th months). Cartilage volume measurements (baseline and 24th month loss) were obtained at five knee plates (medial-tibial, lateral-tibial, medial-femoral, lateral-femoral and patellar), and standardized values were analysed. Multivariate logistic regression was used with adjustment for known confounders. Artificial-Neural-Network analysis was conducted by Multi-Layer-Perceptrons (MLPs) including baseline determinants, and baseline (1) and interval changes (2) in cartilage volumes. Results: Larger baseline lateral-femoral cartilage volume was predictive of medial JSL (OR: 1.29 (1.01–1.64)). Greater initial 24th month lateral-femoral cartilage volume-loss (OR: 0.48 (0.27–0.84)) had protective effect on medial JSL during 24–48th months of study. Baseline and interval changes in lateral-femoral cartilage volume, were the most important estimators for medial JSL progression (importance values: 0.191(0.177–0.204), 0.218(0.207–0.228)) in the ANN analyses. Conclusions: Cartilage volumes (both at baseline and their change during the initial 24 months) in the lateral femoral plate were predictive of medial JSL progression. Key Points: • Baseline lateral femoral cartilage volume is directly associated with medial JSL progression. • 24-month lateral femoral cartilage loss is inversely associated with medial JSL progression. • Lateral femoral cartilage volume is most important in association with medial JSL progression.",
keywords = "Cartilage, Knee osteoarthritis, Logistic models, Magnetic resonance imaging, Neural networks",
author = "Nima Hafezi-Nejad and Ali Guermazi and Roemer, {Frank W.} and Hunter, {David J.} and Dam, {Erik B.} and Bashir Zikria and Kwoh, {C. Kent} and Shadpour Demehri",
note = "Funding Information: The research leading to these results has received funding from the D-BOARD consortium, a European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 305815. The OAI collection was provided by the Osteoarthritis Initiative with the cartilage and menisci segmentations performed by iMorphics. The OAI is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation, GlaxoSmithKline; and Pfizer, Inc. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners. Funding Information: Scientific and financial support for the FNIH OA Biomarkers Consortium and the study are made possible through grants, direct and in-kind contributions provided by: AbbVie; Amgen Inc.; Arthritis Foundation; Bioiberica S.A.; DePuy Mitek, Inc.; Flexion Therapeutics, Inc.; GlaxoSmithKline; Merck Serono; Rottapharm | Madaus; Sanofi; Stryker; The Pivotal OAI MRI Analyses (POMA) Study, NIH HHSN2682010000. We thank the Osteoarthritis Research Society International (OARSI) for their leadership and expertise on the FNIH OA Biomarker Consortium project. Private sector funding for the Consortium and OAI is managed by the FNIH. We also gratefully acknowledge financial support from the Danish Research Foundation (“Den Danske Forskningsfond”). The research leading to these results has received funding from the D-BOARD consortium, a European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 305815. The OAI collection was provided by the Osteoarthritis Initiative with the cartilage and menisci segmentations performed by iMorphics. Publisher Copyright: {\textcopyright} 2016, European Society of Radiology.",
year = "2017",
month = feb,
day = "1",
doi = "10.1007/s00330-016-4393-4",
language = "English (US)",
volume = "27",
pages = "464--473",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",
number = "2",
}